PRRT2 and cancer: Notably, the RhoGAP DLC1, a tumor suppressor protein inactivating RhoA in many types of cancer [55], is phosphorylated by PKC/PKD protein kinases on Ser residues, which create binding sites for 14-3-3 proteins.